Nasal sprays for People with Autism

a nasal spray containing the hormone oxytocin is specially created by researchers to help people with autism to be more sociable.

Researchers conducted a study of 13 people with autism, both of which have a high or low levels of intelligence. Participants who inhaled spray (spray) was reported to be more able to interact with each other than participants who did not inhale spray.

People with autism are known difficulties in communicating, particularly eye contact. But by adding the hormone oxytocin in the body, it can be overcome. Oxytocin is known as a key to improving the dissemination and understanding attitude.

"The addition of the hormone oxytocin to autistic patients with high-level ones, can respond to others and show more social behavior," said Elissar Andari of the Cognitive Science Institutes des as reported by the Telegraph, Monday (15/02/2010).

In his presentation at the Mediterranean Conference of Neuroscience in Egypt, oxytocin therapy is recommended as an alternative treatment for autism. Around 500,000 British people are reported to have autism, and the condition makes the sufferer unable to work as a school or other normal person.

In addition to problems with communication, autism is also very sensitive to sound, touch, taste, smell or color. Treatment varies depending on the level of autism, but it takes a long time.

Earlier in the year 2007, the nasal spray for people with autism ever created by Stan Kurtz, researchers from the Autism Research Institute is also having a child with autism.

Not only autism, other diseases such as ADHD, dyslexia, and diseases associated with immune system can also be overcome by spray containing material methylcobalamin (MB12) is.

Effects of MB12 Nasal Spray can be seen in minutes and even seconds, and the effect can last up to 24 hours. However, these effects could be different for each person, depending on the level of illness.

The price of a bottle of MB12 Nasal Spray can be used for 45 to 90 days is U.S. $ 40 or Rp 400,000 (U.S. 10.000/dolar rate).